News & Updates

Is it safe to use biologic drugs in pregnancy?

05 Jul 2023 by

Among the biologic drugs used during pregnancy, the most common is tumour necrosis factor-α antagonist (etanercept-infliximab-adalimumab), results of a clinical review have shown.

Is it safe to use biologic drugs in pregnancy?

05 Jul 2023

Semaglutide a useful weight-loss treatment option for men, women

05 Jul 2023

In the treatment of obesity, semaglutide works for both men and women, according to the results of a network meta-analysis.

Semaglutide a useful weight-loss treatment option for men, women

05 Jul 2023

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

04 Jul 2023

The periconceptional use of methotrexate among men does not contribute to an increase in the risk of congenital anomalies, preterm birth (PTB), and being small for gestational age (SGA), but it may lead to a temporary decrease in fertility, according to a study.

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

04 Jul 2023

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

04 Jul 2023 by

For individuals with bipolar disorder (BPD), attention-deficit/hyperactive disorder (ADHD) medications help lower the risk of suicidal behaviour, according to data from a comparative effectiveness research study.

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

04 Jul 2023

Migraine tied to adverse pregnancy outcomes

04 Jul 2023 by

Pregnant women with migraine appear to have an increased likelihood of experiencing pre-eclampsia, low birth weight, peripartum mental illness, preterm birth, and placental abruption, according to a study presented at the recent RCOG 2023.

Migraine tied to adverse pregnancy outcomes

04 Jul 2023

Lower LDL-C target a better bet for adverse CV event prevention after stroke

04 Jul 2023

A treatment strategy of targeting a low-density lipoprotein cholesterol (LDL-C) of <70 mg/dL leads to a significant reduction in the composite of adverse cardiovascular (CV) events in patients who have had stroke as compared with an LDL-C target of 100 mg/dL, according to data from the Treat Stroke to Target (TST) trial.

Lower LDL-C target a better bet for adverse CV event prevention after stroke

04 Jul 2023

Individuals with overactive bladder sleep poorly

03 Jul 2023

Sleep disturbance appears to be common among individuals with overactive bladder (OAB), regardless of treatment, as reported in a study.

Individuals with overactive bladder sleep poorly

03 Jul 2023

Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D

03 Jul 2023

In the treatment of individuals with insulin-naïve type 2 diabetes (T2D), once-weekly icodec yields superior HbA1c reduction compared with once-daily degludec, according to the results of a phase IIIa trial.

Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D

03 Jul 2023

Heparin unable to prevent miscarriages in women with inherited thrombophilia

01 Jul 2023 by

Daily shots of low-molecular weight heparin (LMWH) fall short of improving live birth rates for women with a history of at least two pregnancy losses and inherited thrombophilia, according to the results of the open-label trial ALIFE2.

Heparin unable to prevent miscarriages in women with inherited thrombophilia

01 Jul 2023

Original New Drug Application Approvals by US FDA (16-30 June 2023)

01 Jul 2023

New drug applications approved by US FDA as of 16-30 June 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 June 2023)

01 Jul 2023

News & Updates

Filter by Specialty:

Specialty:

Is it safe to use biologic drugs in pregnancy?

Is it safe to use biologic drugs in pregnancy?

Semaglutide a useful weight-loss treatment option for men, women

Semaglutide a useful weight-loss treatment option for men, women

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

Migraine tied to adverse pregnancy outcomes

Migraine tied to adverse pregnancy outcomes

Lower LDL-C target a better bet for adverse CV event prevention after stroke

Lower LDL-C target a better bet for adverse CV event prevention after stroke

Individuals with overactive bladder sleep poorly

Individuals with overactive bladder sleep poorly

Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D

Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D

Heparin unable to prevent miscarriages in women with inherited thrombophilia

Heparin unable to prevent miscarriages in women with inherited thrombophilia

Original New Drug Application Approvals by US FDA (16-30 June 2023)

Original New Drug Application Approvals by US FDA (16-30 June 2023)